Compare IDEXX Laboratories, Inc. (IDXX) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Wix.Com Ltd — how do they compare? IDEXX Laboratories, Inc. trades at $553.81 (market cap $44.48B), while Wix.Com Ltd trades at $51.44 (market cap $2.23B). The key difference: IDEXX Laboratories, Inc. is far larger — about 19.9× Wix.Com Ltd's market cap. Which is the better fit depends on your goals.
| IDXX | WIX | |
|---|---|---|
Market Cap | $44.48B | $2.23B |
Sector | Health | Technology |
52-Week High | $766.68 | $184.24 |
52-Week Low | $520.87 | $40.43 |
Enterprise Value | $45.38B | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Wix trades at $53.34, up 3.67% on the day, with a bearish technical signal and mixed fundamentals. Revenue grew to $1.99B in 2025, but net income fell to $50.65M with a negative margin of -1.97%. The stock faces headwinds from recent earnings misses and legal investigations, yet maintains strong analyst support with a consensus price target of $83.07.
The outlook is cautious due to high valuation multiples and operational risks, but long-term growth potential exists if Wix can leverage AI tools and partnerships to improve profitability. Key risks include competitive pressure and ongoing legal scrutiny, while institutional sentiment remains predominantly bullish.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
